DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $69,000 | -75.4% | 17,360 | -69.7% | 0.00% | -100.0% |
Q3 2019 | $281,000 | -15.4% | 57,311 | +5.2% | 0.00% | -50.0% |
Q2 2019 | $332,000 | +13.3% | 54,502 | +8.0% | 0.00% | 0.0% |
Q1 2019 | $293,000 | -55.6% | 50,455 | +3.0% | 0.00% | -50.0% |
Q4 2018 | $660,000 | -29.7% | 49,005 | +1.3% | 0.00% | -20.0% |
Q3 2018 | $939,000 | -23.3% | 48,383 | +1.0% | 0.01% | -16.7% |
Q2 2018 | $1,224,000 | +36.5% | 47,905 | +7.6% | 0.01% | +20.0% |
Q1 2018 | $897,000 | -0.2% | 44,508 | -0.7% | 0.01% | +25.0% |
Q4 2017 | $899,000 | +2.5% | 44,816 | +5.8% | 0.00% | -20.0% |
Q3 2017 | $877,000 | +2640.6% | 42,359 | +1873.9% | 0.01% | – |
Q2 2017 | $32,000 | -99.2% | 2,146 | -98.5% | 0.00% | -100.0% |
Q3 2016 | $4,083,000 | -18.3% | 145,753 | +2.1% | 0.02% | -21.9% |
Q2 2016 | $4,997,000 | +27.7% | 142,771 | 0.0% | 0.03% | +23.1% |
Q1 2016 | $3,912,000 | -43.1% | 142,771 | -29.0% | 0.03% | -38.1% |
Q4 2015 | $6,877,000 | +42.0% | 200,971 | +19.2% | 0.04% | +35.5% |
Q3 2015 | $4,843,000 | -24.8% | 168,571 | +17.2% | 0.03% | -16.2% |
Q2 2015 | $6,438,000 | -3.2% | 143,871 | -25.2% | 0.04% | -2.6% |
Q1 2015 | $6,649,000 | +12.0% | 192,271 | -11.4% | 0.04% | +8.6% |
Q4 2014 | $5,938,000 | – | 216,971 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |